Donal P McLornan (D P McLornan, D McLornan, Donal McLornan, Donal Mclornan)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 104

Top Venues

Bone marrow transplantation

British journal of haematology

Leukemia

EJHaem

This page only lists publications with an associated author ORCID identifier.

Publications

María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Donal P McLornan, Tomasz Czerw, Gandhi Laurent Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, Deepti H Radia
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee. Leukemia 38 (4) (2024)
Angela Hwang, Patrick J Hayden, Charlotte Pawlyn, Donal P McLornan, Laurent Garderet
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British journal of haematology (2024)
Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Donal P McLornan, Tomasz Czerw, Gandhi Laurent Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, Deepti H Radia
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee. Leukemia 38 (4) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Donal P McLornan, Tomasz Czerw, Gandhi Laurent Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, Deepti H Radia
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee. Leukemia 38 (4) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Francesco Onida, Luuk Gras, Junran Ge, Linda Koster, Rose-Marie Hamladji, Jenny Byrne, Daniele Avenoso, Mahmoud Aljurf, Marie Robin, Kazimierz Halaburda, Jakob Passweg, Urpu Salmenniemi, Henrik Sengeloev, Jane Apperley, Andrew Clark, Péter Reményi, Elena Morozova, Francesca A M Kinsella, Stig Lenhoff, Arnold Ganser, Ka Lung Wu, Antonio Perez-Martinez, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Guillermo OrtÍ, Hugues de Lavallade, Ibrahim Yakoub-Agha, Donal P McLornan, Yves Chalandon
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT. British journal of haematology (2024)
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Angela Hwang, Patrick J Hayden, Charlotte Pawlyn, Donal P McLornan, Laurent Garderet
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British journal of haematology (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Francesco Onida, Luuk Gras, Junran Ge, Linda Koster, Rose-Marie Hamladji, Jenny Byrne, Daniele Avenoso, Mahmoud Aljurf, Marie Robin, Kazimierz Halaburda, Jakob Passweg, Urpu Salmenniemi, Henrik Sengeloev, Jane Apperley, Andrew Clark, Péter Reményi, Elena Morozova, Francesca A M Kinsella, Stig Lenhoff, Arnold Ganser, Ka Lung Wu, Antonio Perez-Martinez, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Guillermo OrtÍ, Hugues de Lavallade, Ibrahim Yakoub-Agha, Donal P McLornan, Yves Chalandon
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT. British journal of haematology 204 (6) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Francesco Onida, Luuk Gras, Junran Ge, Linda Koster, Rose-Marie Hamladji, Jenny Byrne, Daniele Avenoso, Mahmoud Aljurf, Marie Robin, Kazimierz Halaburda, Jakob Passweg, Urpu Salmenniemi, Henrik Sengeloev, Jane Apperley, Andrew Clark, Péter Reményi, Elena Morozova, Francesca A M Kinsella, Stig Lenhoff, Arnold Ganser, Ka Lung Wu, Antonio Perez-Martinez, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Guillermo OrtÍ, Hugues de Lavallade, Ibrahim Yakoub-Agha, Donal P McLornan, Yves Chalandon
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT. British journal of haematology 204 (6) (2024)
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, Uwe Platzbecker, Katja Sockel, Juergen Finke, Nicolaus M Kröger, Edouard Forcade, Arnon Nagler, Matthias Eder, Johanna Tischer, Annoek E C Broers, Jürgen H E Kuball, Keith M O Wilson, Mathilde M Hunault-Berger, Matthew Collin, Domenico Russo, Lucía López Corral, Grzegorz Helbig, Alberto Mussetti, Christof Scheid, Carmelo Gurnari, Kavita Raj, Joanna Drozd-Sokołowska, Ibrahim Yakoub Agha, Marie Robin, Donal P McLornan
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (3) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Angela Hwang, Patrick J Hayden, Charlotte Pawlyn, Donal P McLornan, Laurent Garderet
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British journal of haematology 204 (4) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, Uwe Platzbecker, Katja Sockel, Juergen Finke, Nicolaus M Kröger, Edouard Forcade, Arnon Nagler, Matthias Eder, Johanna Tischer, Annoek E C Broers, Jürgen H E Kuball, Keith M O Wilson, Mathilde M Hunault-Berger, Matthew Collin, Domenico Russo, Lucía López Corral, Grzegorz Helbig, Alberto Mussetti, Christof Scheid, Carmelo Gurnari, Kavita Raj, Joanna Drozd-Sokołowska, Ibrahim Yakoub Agha, Marie Robin, Donal P McLornan
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Giulia Ciangola, Enrico Santinelli, Donal P McLornan, Simona Pagliuca, Carmelo Gurnari
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond? Bone marrow transplantation (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Giulia Ciangola, Enrico Santinelli, Donal P McLornan, Simona Pagliuca, Carmelo Gurnari
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond? Bone marrow transplantation 59 (4) (2024)
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, Uwe Platzbecker, Katja Sockel, Juergen Finke, Nicolaus M Kröger, Edouard Forcade, Arnon Nagler, Matthias Eder, Johanna Tischer, Annoek E C Broers, Jürgen H E Kuball, Keith M O Wilson, Mathilde M Hunault-Berger, Matthew Collin, Domenico Russo, Lucía López Corral, Grzegorz Helbig, Alberto Mussetti, Christof Scheid, Carmelo Gurnari, Kavita Raj, Joanna Drozd-Sokołowska, Ibrahim Yakoub Agha, Marie Robin, Donal P McLornan
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (3) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Donal P McLornan, Tomasz Czerw, Gandhi Laurent Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, Deepti H Radia
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee. Leukemia (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Donal P McLornan, Tomasz Czerw, Gandhi Laurent Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, Deepti H Radia
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee. Leukemia (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Angela Hwang, Patrick J Hayden, Charlotte Pawlyn, Donal P McLornan, Laurent Garderet
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British journal of haematology 204 (4) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Giulia Ciangola, Enrico Santinelli, Donal P McLornan, Simona Pagliuca, Carmelo Gurnari
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond? Bone marrow transplantation 59 (4) (2024)
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas Schaap, Concepcion Herrera Arroyo, Christine Schuermans, Britta Besemer, Monika Engelhardt, Jürgen H E Kuball, Mariagrazia Michieli, Natalie Schub, Keith M O Wilson, Jean Henri Bourhis, Maria-Victoria Mateos-Manteca, Neil Rabin, Edgar Jost, Nicolaus M Kröger, José María M Moraleda, Tommaso Za, Patrick J Hayden, Meral Beksac, Donal P McLornan, Stefan O Schönland, Salomon Manier
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT. Bone marrow transplantation (2023)
Juan Carlos Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, Nicolaus M Kröger, Marie Robin, Moniek de Witte, Juergen Finke, Maria Chiara Finazzi, Annoek Broers, Ludek Raida, Nicolaas Schaap, Patrizia Chiusolo, Mareike Verbeek, Carin L E Hazenberg, Kazimierz Halaburda, Alexander Dmitrievich Kulagin, Hélène Labussière-Wallet, Tobias Gedde-Dahl, Werner Rabitsch, Kavita Raj, Joanna Drozd-Sokołowska, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Ibrahim Yakoub Agha, Donal P McLornan
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. Bone marrow transplantation (2023)
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K Rabin, Anne Marie Stoppa, Ellen Meijer, Jean-Baptiste Mear, Sacha Zeerleder, Jiri Mayer, Roland Fenk, Nathalie Fegueux, Patrice Chevallier, Eva Konirova, John A Snowden, Monika Engelhardt, Kim Orchard, Cyrille Hulin, Nicolaas Schaap, Claudia Sossa, Ahmet Elmaagacli, Donal P McLornan, Patrick J Hayden, Stefan O Schönland, Ibrahim Yakoub Agha
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT. Bone marrow transplantation (2023)
Marie Robin, Luuk Gras, Linda Koster, Riccardo Saccardi, Juergen Finke, Edouard Forcade, Montserrat Rovira, Guido Kobbe, Péter Reményi, Jane F Apperley, Arghirescu Smaranda, Jacques-Olivier Bay, Jochen Casper, Liesbeth C de Wreede, Sebastian Giebel, Giovanni Grillo, Inmaculada Heras, Victoria Potter, Johanna Tischer, Ilze Trociukas, David Nachbaur, Joanna Drozd-Sokołowska, Kavita Raj, Carmelo Gurnari, Ibrahim Yakoub-Agha, Francesco Onida, Christof Scheid, Donal P McLornan
Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature. Bone marrow transplantation (2023)
Donal P McLornan, Bethan Psaila, Joanne Ewing, Andrew J Innes, Siamak Arami, Jessica Brady, Nauman M Butt, Catherine Cargo, Nicholas C P Cross, Sebastian Francis, Rebecca Frewin, Mamta Garg, Anna L Godfrey, Anna Green, Alesia Khan, Steve Knapper, Jonathan Lambert, Andrew McGregor, Mary Frances Frances McMullin, Jyoti Nangalia, Pratap Neelakantan, Claire Woodley, Adam J Mead, Tim C P Somervaille, Claire N Harrison, null null
The management of myelofibrosis: A British Society for Haematology Guideline. British journal of haematology (2023)
Donal P McLornan, Anna L Godfrey, Anna Green, Rebecca Frewin, Siamak Arami, Jessica Brady, Nauman M Butt, Catherine Cargo, Joanne Ewing, Sebastian Francis, Mamta Garg, Claire N Harrison, Andrew J Innes, Alesia Khan, Steve Knapper, Jonathan Lambert, Adam J Mead, Andrew McGregor, Pratap Neelakantan, Bethan Psaila, Tim C P Somervaille, Claire Woodley, Jyoti Nangalia, Nicholas C P Cross, Mary Frances Frances McMullin, null null
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline. British journal of haematology (2023)
Olivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, Nienke Zinger, Peter Dreger, Martin Bornhäuser, Vladan Vucinic, Christof Scheid, Jan J Cornelissen, Thomas Schroeder, Pavel Jindra, Henrik Sengeloev, Stephanie Nguyen Quoc, Matthias Stelljes, Igor Wolfgang Blau, Jiri Mayer, Shankara Paneesha, Patrice Chevallier, Edouard Forcade, Nicolaus M Kröger, Didier Blaise, John G Gribben, Bendt Nielsen, Jan-Erik Johansson, Charalampia Kyriakou, Yves Beguin, Pietro Pioltelli, Maria Antonia Sampol, Donal P McLornan, Johannes Schetelig, Patrick J Hayden, Ibrahim Yakoub Agha
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2023)
Dina Mahdi, Jessica Spiers, Alexandros Rampotas, Nicola Polverelli, Donal P McLornan
Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress? British journal of haematology (2023)
Olivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, Nienke Zinger, Peter Dreger, Martin Bornhäuser, Vladan Vucinic, Christof Scheid, Jan J Cornelissen, Thomas Schroeder, Pavel Jindra, Henrik Sengeloev, Stephanie Nguyen Quoc, Matthias Stelljes, Igor Wolfgang Blau, Jiri Mayer, Shankara Paneesha, Patrice Chevallier, Edouard Forcade, Nicolaus M Kröger, Didier Blaise, John G Gribben, Bendt Nielsen, Jan-Erik Johansson, Charalampia Kyriakou, Yves Beguin, Pietro Pioltelli, Maria Antonia Sampol, Donal P McLornan, Johannes Schetelig, Patrick J Hayden, Ibrahim Yakoub Agha
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2023)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Selim Corbacioglu, Rafael De la Cámara LLanzá, Harry Dolstra, Bertram Glass, Raffaella Greco, Donal P McLornan, Bénédicte Neven, Régis Peffault de Latour, Zinaida Perić, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey. Bone marrow transplantation (2023)
V Potter, L Gras, L Koster, Nicolaus M Kröger, K Sockel, A Ganser, Juergen Finke, H Labussiere-Wallet, R Peffault de Latour, Y Koc, U Salmenniemi, L Smidstrup Friis, Pavel Jindra, Thomas Schroeder, Johanna Tischer, Mutlu Arat, M Pascual Cascon, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, C Scheid, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone marrow transplantation (2023)
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K Rabin, Anne Marie Stoppa, Ellen Meijer, Jean-Baptiste Mear, Sacha Zeerleder, Jiri Mayer, Roland Fenk, Nathalie Fegueux, Patrice Chevallier, Eva Konirova, John A Snowden, Monika Engelhardt, Kim Orchard, Cyrille Hulin, Nicolaas Schaap, Claudia Sossa, Ahmet Elmaagacli, Donal P McLornan, Patrick J Hayden, Stefan O Schönland, Ibrahim Yakoub Agha
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT. Bone marrow transplantation (2023)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Selim Corbacioglu, Rafael De la Cámara LLanzá, Harry Dolstra, Bertram Glass, Raffaella Greco, Donal P McLornan, Bénédicte Neven, Régis Peffault de Latour, Zinaida Perić, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey. Bone marrow transplantation (2023)
Marie Robin, Luuk Gras, Linda Koster, Nico Gagelmann, Gwendolyn van Gorkom, Matthias Ederr, Maija Itälä-Remes, Tsila Zukerman, Yves Beguin, Nicolaas Schaap, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Liesbeth C de Wreede, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Juan Carlos Carlos Hernández-Boluda, Nicolaus Kröger, Ibrahim Yakoub-Agha, Donal P McLornan
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT. British journal of haematology (2023)
Anna Waszczuk-Gajda, Luuk Gras, Liesbeth C de Wreede, Tiarlan Sirait, Arpad Illes, Zubeyde Nur Ozkurt, John A Snowden, Mutlu Arat, Claude Eric Bulabois, Judith Niederland, Matjaz Sever, Shankara Paneesha, Victoria Potter, Alain Gadisseur, Thomas Chalopin, Gwendolyn Van Gorkom, Joaquin Martínez López, Tessa Kerre, Joanna Drozd-Sokołowska, Kavita Raj, Patrick J Hayden, Meral Beksac, Ibrahim Yakoub Agha, Donal P McLornan, Stefan O Schönland
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT. Bone marrow transplantation (2023)
Ibrahim Yakoub Agha, Raffaella Greco, Francesco Onida, Rafael De la Cámara LLanzá, Fabio Ciceri, Selim Corbacioglu, Harry Dolstra, Bertram Glass, Michelle Kenyon, Donal P McLornan, Bénédicte Neven, Regis Peffault de Latour, Zinaida Perić, Annalisa Ruggeri, John A Snowden, Anna Sureda, Isabel Sánchez-Ortega
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone marrow transplantation (2023)
Bhagirathbhai R Dholaria, Aleksandar Radujkovic, Noel Estrada-Merly, Tiarlan Sirait, Soyoung Kim, Juan Carlos Carlos Hernández-Boluda, Tomasz Czerw, Patrick J Hayden, Ankit Kansagra, Vincent T Ho, Taiga Nishihori, Paul Shaughnessy, Bart Scott, Ryotaro Nakamura, Betul Oran, Mohamed A Kharfan-Dabaja, Bipin N Savani, Donal P McLornan, Ibrahim Yakoub-Agha, Wael Saber
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis. British journal of haematology 198 (4) (2022)
Patrick Harrington, Katie J Doores, Jamie Saunders, Marc de Lord, Chandan Saha, Thomas Lechmere, Hataf Khan, Ho Pui Jeff Lam, Amy O' Reilly, Claire Woodley, Susan Asirvatham, Richard Dillon, Natalia Curto-Garcia, Jennifer O' Sullivan, Shahram Kordasti, Kavita Raj, Michael H Malim, Deepti Radia, Donal P McLornan, Claire Harrison, Hugues de Lavallade
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib. Blood cancer journal 12 (4) (2022)
Joanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, Mohsen Al Zahrani, Jakob Passweg, Jenny Byrne, Aloysius Ho, Xiao-Jun Huang, Nicolaus M Kröger, Jiri Mayer, Domenico Russo, Ann De Becker, Abdelghani Tbakhi, Aspasia Stamatoullas, Thomas Valerius, Patrick J Hayden, Donal P McLornan, Francesco Onida, Christof Scheid, Marie Robin, Ibrahim Yakoub Agha
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2022)
Patrick Harrington, Richard Dillon, Deepti H Radia, Donal P McLornan, Claire Woodley, Susan Asirvatham, Kavita Raj, Natalia Curto-Garcia, Jamie Saunders, Shahram Kordasti, Claire N Harrison, Hugues de Lavallade
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype. British journal of haematology 198 (6) (2022)
Ruben A Mesa, Claire Harrison, Stephen T Oh, Aaron T Gerds, Vikas K Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean-Jacques Kiladjian, Ewa Lech-Maranda, Donal P McLornan, Alessandro M Vannucchi, Uwe Platzbecker, Mei Huang, Bryan Strouse, Barbara J Klencke, Srdan Verstovsek
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis. Leukemia 36 (9) (2022)
Juan Carlos Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, Luuk Gras, Rodrigo Martino Bofarull, Emmanouil Nikolousis, Jürgen Finke, Anabelle Chinea, Alessandro Rambaldi, Marie Robin, Riccardo Saccardi, Annalisa Natale, John A Snowden, Panagiotis Tsirigotis, Carlos Vallejo, Gerald Wulf, Blanca Xicoy, Domenico Russo, Johan Maertens, Etienne Daguindau, Stig Lenhoff, Patrick J Hayden, Tomasz Czerw, Donal P McLornan, Ibrahim Yakoub Agha
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone marrow transplantation 57 (3) (2022)
Carmelo Gurnari, Donal P McLornan
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 57 (11) (2022)
Donal P McLornan, Luuk Gras, Ivonne Martin, Tiarlan Sirait, Thomas Schroeder, Igor Wolfgang Blau, Jürgen Kuball, Jenny Byrne, Matthew Collin, Michael Stadler, Déborah Desmier, Urpu Salmenniemi, Pavel Jindra, Natalia Mikhailova, Stig Lenhoff, Jose Rifón, Marie Robin, Montserrat Rovira, Hendrik Veelken, Alicja Sadowska-Klasa, Marco Zecca, Patrick J Hayden, Tomasz Czerw, Juan Carlos Carlos Hernández-Boluda, Ibrahim Yakoub-Agha
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT. British journal of haematology 198 (1) (2022)
Donal P McLornan, Rupen Hargreaves, Juan Carlos Carlos Hernández-Boluda, Claire N Harrison
How I manage myeloproliferative neoplasm-unclassifiable: Practical approaches for 2022 and beyond. British journal of haematology 197 (4) (2022)
Donal P McLornan, D J Eikema, T Czerw, N Kröger, L Koster, Hans Christian Reinhardt, E Angelucci, Marie Robin, M Bornhäuser, J Passweg, A Clark, Jan Vydra, I E Blau, R Niittyvuopio, U Platzbecker, J J Cornelissen, P Chevallier, M Srour, D Stamatovic, J Martinez-Lopez, L de Wreede, Patrick J Hayden, Juan Carlos Carlos Hernández-Boluda, Ibrahim Yakoub Agha
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis. Bone marrow transplantation 56 (9) (2021)
Vipul Sheth, Victoria Potter, Hugues de Lavallade, Shreyans Gandhi, Austin G Kulasekararaj, Pramila Krishnamurthy, Varun Mehra, Francesco Dazzi, Ghulam Mufti, Antonio Pagliuca, Donal P McLornan, Kavita Raj
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy-Is it prognostic?-a single-center retrospective study. Blood cancer journal 11 (7) (2021)
Nicolaus M Kröger, Giulia Sbianchi, Tiarlan Sirait, Christine Wolschke, Dietrich Beelen, Jakob Passweg, Marie Robin, Radovan Vrhovac, Grzegorz Helbig, Katja Sockel, Eibhlin Conneally, Marie Thérèse Rubio, Yves Beguin, Jürgen Finke, Paolo Bernasconi, Elena Morozova, Johannes Clausen, Peter von dem Borne, Nicolaas Schaap, Wilfried Schroyens, Francesca Patriarca, Nicola Di Renzo, Zeynep Arzu Yeğin, Patrick Hayden, Donal P McLornan, Ibrahim Yakoub Agha
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia 35 (12) (2021)
Donal P McLornan, Juan Carlos Carlos Hernández-Boluda, Tomasz Czerw, Nicholas C P Cross, H Joachim Deeg, Marcus Ditschkowski, Mufaddal T Moonim, Nicola Polverelli, Marie Robin, Mahmoud Aljurf, Eibhlin Conneally, Patrick Hayden, Ibrahim Yakoub Agha
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party. Leukemia 35 (9) (2021)
Patrick Harrington, Katie J Doores, Deepti H Radia, Amy O'Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal P McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O'Sullivan, Kavita Raj, Shahram Kordasti, Michael H Malim, Claire Harrison, Hugues de Lavallade
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia. British journal of haematology 194 (6) (2021)
Paul Deschamps, Mufaddal Moonim, Deepti H Radia, Natalia Curto-Garcia, Claire Woodley, Sarah Bassiony, Jennifer O'Sullivan, Patrick Harrington, Kavita Raj, Yvonne Francis, Shahram Kordasti, Sahra Ali, Claire N Harrison, Donal P McLornan
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre. British journal of haematology 193 (4) (2021)
Patrick Harrington, Claire N Harrison, Richard Dillon, Deepti H Radia, Katayoun Rezvani, Kavita Raj, Claire Woodley, Natalia Curto-Garcia, Jennifer O'Sullivan, Jamie Saunders, Shahram Kordasti, Sahra Ali, Hugues de Lavallade, Donal P McLornan
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). British journal of haematology 193 (4) (2021)
Giorgia Battipaglia, Katya Mauff, Lotus Wendel, Emanuele Angelucci, Mohamad Mohty, William Arcese, Stella Santarone, Marie Therese Rubio, Nicolaus Kroger, Maria Laura Fox, Didier Blaise, Anna Paola Iori, Renato Fanin, Yves Chalandon, Pietro Pioltelli, Giuseppe Marotta, Patrizia Chiusolo, Matjaz Sever, Carlos Solano, Nathalie Contentin, Liesbeth C de Wreede, Tomasz Czerw, Juan Carlos Carlos Hernández-Boluda, Patrick Hayden, Donal P McLornan, Ibrahim Yakoub Agha
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 56 (7) (2021)
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, Linda Koster, Nicolaus M Kröger, Marie Robin, Johan Maertens, Patrice Chevallier, Emma Watz, Xavier Poire, John A Snowden, Jürgen H E Kuball, Francesca A M Kinsella, Didier Blaise, Péter Reményi, Jean-Baptiste Mear, Jörg Cammenga, Marie Thérèse Rubio, Sebastien Maury, Etienne Daguindau, Damian Finnegan, Patrick J Hayden, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan, Ibrahim Yakoub Agha
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2021)
Patrick Harrington, Hugues de Lavallade, Katie J Doores, Amy O'Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O'Sullivan, Kavita Raj, Shahram Kordasti, Michael H Malim, Claire N Harrison, Donal P McLornan
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms. Leukemia 35 (12) (2021)
Mitja Nabergoj, Katya Mauff, Marie Robin, Nicolaus Kröger, Emanuele Angelucci, Xavier Poire, Jakob Passweg, Aleksandar Radujkovic, Uwe Platzbecker, Stephen Robinson, Alessandro Rambaldi, Søren Lykke Petersen, Fridrich Stölzel, Matthias Stelljes, Fabio Ciceri, Jiri Mayer, Marco Ladetto, Liesebeth C de Wreede, Linda Koster, Patrick J Hayden, Tomasz Czerw, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan, Yves Chalandon, Ibrahim Yakoub Agha
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT. Bone marrow transplantation 56 (8) (2021)
Ioanna Lazana, Azim Mohamedali, Frances Smith, Hugues de Lavallade, Donal P McLornan, Kavita Raj
Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis. British journal of haematology 192 (1) (2020)
Donal P McLornan, Claire N Harrison
Forging ahead or moving back: dilemmas and disappointments of novel agents for myeloproliferative neoplasms. British journal of haematology 191 (1) (2020)
Donal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, Victoria Potter, Dietrich Beelen, Donald Bunjes, Henrik Sengeloev, Aleksandar Radujkovic, Jakob Passweg, Yves Chalandon, Nicolaus Kröger, Gerald G Wulf, Jan-Erik Johansson, Fabio Ciceri, Martin Bornhäuser, Ernst Holler, Blandine Guffroy, Sonja Martin, Andreas Neubauer, Martin Gramatski, Marie Robin, Simona Iacobelli, Patrick Hayden, Juan C Hernández Boluda, Tomasz Czerw, Ibrahim Yakoub-Agha
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. British journal of haematology 190 (3) (2020)
Rob S Sellar, Varun Mehra, Thomas Andrew Fox, Andrew Grigg, Austin Kulasekararaj, Anita Sarma, Hugues de Lavallade, Donal P McLornan, Kavita Raj, Ghulam J Mufti, Antonio Pagliuca, Stephen Mackinnon, Ronjon Chakraverty, Adele K Fielding, Ben Carpenter, Panagiotis D Kottaridis, Asim Khwaja, Karl S Peggs, Kirsty J Thomson, Emma C Morris, Victoria T Potter
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia. British journal of haematology 187 (1) (2019)

Donal P McLornan.css-eqlu8i{font-size:small;padding-left:4px;} (D P McLornan, D McLornan, Donal McLornan, Donal Mclornan)

Publication Activity (10 Years)

Top Topics

Top Venues

Donal P McLornan (D P McLornan, D McLornan, Donal McLornan, Donal Mclornan)